Barclays lowered the firm’s price target on Acadia Healthcare (ACHC) to $43 from $76 and keeps an Overweight rating on the shares. The company noted about $50M in startup costs next year, which was higher than expectations and offsets a meaningful portion of the Tennessee SDP, the analyst tells investors in a research note.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare price target lowered to $64 from $94 at RBC Capital
- Acadia Healthcare price target lowered to $70 from $91 at TD Cowen
- Acadia Healthcare price target lowered to $45 from $75 at Deutsche Bank
- Acadia Healthcare Reports Strong Q3 2024 Results
- Closing Bell Movers: Microsoft, Meta both down about 3% despite earnings beats